医学
药品审批
药品
梅德林
药理学
法学
政治学
作者
Alex M. Ebied,Hesham Elmariah,Rhonda M. Cooper‐DeHoff
标识
DOI:10.1016/j.amjmed.2021.03.034
摘要
Abstract
In 2020, the US Food and Drug Administration approved 53 novel drugs. Thirty-six of the 53 (68%) drugs were reviewed and approved through an expedited review pathway, and 31 of the 53 (58%) were approved for treatment of a rare disease. This review includes a summary of the novel drugs approved by the US Food and Drug Administration in 2020.
科研通智能强力驱动
Strongly Powered by AbleSci AI